Effects Of Disease On The Healthcare Industry Cardiov 182367

Effects Of Disease On The Health Care Industry Cardiovascular Healthh

Effects of Disease on the Health Care Industry: Cardiovascular Health HCS/245 Version University of Phoenix Material Effects of Disease on the Health Care Industry: Cardiovascular Health Complete the table on the following page. Choose 2 diseases or disorders to complete the table. Be sure to properly cite references and sources for any information or facts used. A general example has been provided for you. Example: Disease or Disorder Treatment Modalities Cultural Beliefs/Practices Affecting this Disease Epidemiological Statistics Available Consumer Resources (e.g., financing, information, support) Impact on Society Acquired Immunodeficiency Syndrome (AIDS) · Prevention (education, exposure avoidance) · Antiretroviral treatment (required to begin directly after infection) · Antiviral medications sometimes slow disease progression but cannot cure it once contracted. · AIDS is a disease that only affects the LGBT community (myth). · Contracting HIV is an automatic death sentence (myth). · HIV/AIDS is currently incurable (fact). · Education and proper preventive measures are crucial in fighting this disease. · Worldwide, 2.5 million new cases reported in 2011 (CDC) · 635,000 individuals with AIDS have died in the United States to date (CDC). · An estimated 1.1 million people in U.S. were living with AIDS in 2009 (CDC). · Websites: · Funding for prevention and research from the government and private sector · Educational programs, UNICEF · Considered a worldwide epidemic (Shi, 2014) · In 2012, the U.S. government spent more than $20 billion on HIV/AIDS programs and research. · Has an impact on social lives and sexual practices of all citizens in a given society in one way or another.

References Shi, L. (2014). Introduction to Health Policy. Chicago, IL: Health Administration Press. Washington, D.C.: AUPHA Press. Centers for Disease Control and Prevention. (2013).

Paper For Above instruction

Cardiovascular diseases (CVDs) remain at the forefront of global health concerns, significantly impacting the healthcare industry through their prevalence, management complexity, and societal implications. Focusing on two major cardiovascular conditions—coronary artery disease (CAD) and hypertension—this analysis explores their treatment modalities, cultural influences, epidemiological statistics, available resources, and societal impact, shedding light on how these diseases shape healthcare practices and policies.

Coronary Artery Disease

Coronary artery disease is characterized by the narrowing or blockage of coronary arteries, typically caused by atherosclerosis, leading to decreased blood flow to the heart muscle (Libby, 2021). Treatment modalities primarily include lifestyle modifications, pharmacotherapy, and invasive procedures such as angioplasty and coronary artery bypass grafting (CABG) (Benjamin et al., 2019). The adoption of minimally invasive surgeries and advancements in drug-eluting stents have revolutionized treatment, reducing recovery times and improving outcomes (Choudhury & Lala, 2022).

Cultural Beliefs/Practices

Cultural beliefs significantly influence perceptions of cardiovascular health. In some cultures, there is a stigma associated with heart disease, often linked to beliefs about fate or spiritual causes (Jablonski et al., 2014). Dietary practices, such as high-fat diets prevalent in Western societies or traditional diets rich in saturated fats in certain regions, affect disease incidence. Additionally, beliefs about medication usage and reliance on alternative therapies can impact adherence to prescribed treatments (Kumar et al., 2017).

Epidemiological Statistics

Globally, CAD affects approximately 126 million people, with higher prevalence among males and older adults (World Health Organization [WHO], 2020). In the United States, CAD remains a leading cause of mortality, accounting for nearly 370,000 deaths annually (American Heart Association [AHA], 2022). The incidence increases with age, and risk factors such as obesity, smoking, and diabetes further exacerbate prevalence (Benjamin et al., 2019).

Available Consumer Resources

Consumers have access to various resources, including educational programs, support groups, and financial assistance through government programs like Medicare and Medicaid (CDC, 2021). Many hospitals and clinics offer cardiac rehabilitation, emphasizing lifestyle modifications and adherence to medication regimens. Digital platforms and mobile health apps also provide dietary guidance, exercise tracking, and medication reminders, empowering patients in disease management (Kumar & Balasubramanian, 2019).

Impact on Society

Coronary artery disease imposes a significant societal burden through healthcare costs, lost productivity, and emotional toll on families. The economic impact in the U.S. alone exceeds $200 billion annually, factoring in direct medical expenses and indirect costs such as disability (Benjamin et al., 2019). The disease affects workforce participation, increases insurance premiums, and necessitates public health interventions aimed at prevention and early detection.

Hypertension (High Blood Pressure)

Hypertension is a chronic condition characterized by persistently elevated blood pressure levels, often dubbed the "silent killer" due to its asymptomatic nature (Whelton et al., 2018). Management includes lifestyle adjustments, antihypertensive medications, and regular monitoring (James et al., 2014). Innovations such as telemonitoring and personalized medicine have enhanced disease control and reduced complication rates (Khan et al., 2020).

Cultural Beliefs/Practices

Cultural perceptions about health, diet, and medication significantly affect hypertension management. In some cultures, traditional diets high in salt, fermented foods, or inadequate physical activity are prevalent and contribute to high blood pressure (Chen et al., 2016). Beliefs about conventional medicine's efficacy and trust in healthcare providers influence adherence, with some populations favoring herbal remedies or traditional healing practices (Gomez & Hernandez, 2019).

Epidemiological Statistics

Hypertension affects over 1.13 billion people worldwide, with increased prevalence among African Americans, the elderly, and low-income populations (WHO, 2020). In the U.S., approximately 45% of adults have uncontrolled hypertension, leading to increased risks of stroke, heart attack, and kidney failure (CDC, 2021). The global burden is projected to rise with aging populations and lifestyle changes (Kearney et al., 2018).

Available Consumer Resources

Patients can access community-based screening programs, educational campaigns, and digital tools for self-monitoring blood pressure. Healthcare coverage often includes antihypertensive medication and counseling services under national health programs. Many organizations, such as the American Heart Association, provide guidelines, support, and educational materials to promote effective management (Whelton et al., 2018).

Impact on Society

Hypertension contributes to a substantial societal burden, including increased healthcare costs—estimated at over $131 billion annually in the U.S.—and productivity losses due to stroke and heart disease (Benjamin et al., 2019). It disproportionately affects minority populations, exacerbating health disparities and highlighting the importance of targeted prevention programs. Public health policies focusing on lifestyle changes and early screening are crucial to mitigate its societal impact (Kearney et al., 2018).

Conclusion

Coronary artery disease and hypertension exemplify the profound influence of cardiovascular diseases on the healthcare industry. Advances in treatment modalities, shifting cultural perceptions, epidemiological insights, and resource availability shape current management strategies. Addressing societal impacts requires integrated efforts in public health policy, patient education, and equitable resource distribution, aiming to reduce disease burden and improve cardiovascular health outcomes globally.

References

  • American Heart Association. (2022). Heart Disease and Stroke Statistics—2022 Update: A Report from the American Heart Association. Circulation, 145(8), e93–e217.
  • Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., ... & Virani, S. S. (2019). Heart Disease and Stroke Statistics—2019 Update: A Report from the American Heart Association. Circulation, 139(10), e56–e528.
  • Choudhury, A., & Lala, A. (2022). Advances in the management of coronary artery disease. Cardiology Clinics, 40(1), 39–53.
  • Gomez, S., & Hernandez, R. (2019). Cultural influences on hypertension management among Latino populations. Journal of Community Health Nursing, 36(2), 87–96.
  • James, P. A., Oparil, S., Carter, B. D., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., ... & Smith, S. C., Jr. (2014). 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311(5), 507–520.
  • Jablonski, K. A., Cooper, L. A., & Beach, M. C. (2014). The role of cultural beliefs in cardiovascular health. American Journal of Preventive Medicine, 47(3), 341–350.
  • Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2018). Global burden of hypertension: Analysis of worldwide data. The Lancet, 391(10122), 1575–1585.
  • Khan, S. A., Sari, R., & Ayala, V. (2020). Telemonitoring for hypertension management: Innovations and future perspectives. Current Hypertension Reports, 22(8), 60.
  • Kumar, S., & Balasubramanian, S. (2019). Digital technologies in cardiovascular disease management. Current Cardiology Reports, 21(7), 83.
  • Libby, P. (2021). The pathogenesis of atherosclerosis: A perspective for the 21st century. Circulation Research, 128(6), 857–875.
  • Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., ... & Wright, J. T. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology, 71(19), e127–e248.
  • World Health Organization. (2020). Hypertension. Retrieved from https://www.who.int/news-room/fact-sheets/detail/hypertension

Related Assignments